We are live on ! Find out more
DGX icon

Quest Diagnostics

485 hedge funds and large institutions have $8.81B invested in Quest Diagnostics in 2014 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 158 increasing their positions, 199 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

1% more capital invested

Capital invested by funds: $8.72B → $8.81B (+$84.4M)

1.01% less ownership

Funds ownership: 102.83%101.82% (-1%)

2% less funds holding

Funds holding: 496485 (-11)

20% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 45

21% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 199

41% less call options, than puts

Call options by funds: $122M | Put options by funds: $206M

Holders
485
Holders Change
-11
Holders Change %
-2.22%
% of All Funds
14.07%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.23%
New
36
Increased
158
Reduced
199
Closed
45
Calls
$122M
Puts
$206M
Net Calls
-$83.5M
Net Calls Change
-$136M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
151
Auxier Asset Management
Oregon
$4.79M -$3.08K -50 -0.1%
U
152
UBS
Switzerland
$4.77M -$2.45M -39,800 -34%
HVC
153
Healthcare Value Capital
New Jersey
$4.68M
EA
154
Euclid Advisors
Connecticut
$4.68M +$361K +5,860 +8%
B
155
BP
United Kingdom
$4.67M +$4.74M +77,000 New
Caisse de Depot et Placement du Quebec (CDPQ)
156
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$4.64M -$160K -2,600 -3%
FM
157
Forward Management
California
$4.63M +$699K +11,340 +16%
ASRS
158
Arizona State Retirement System
Arizona
$4.55M -$160K -2,600 -3%
DCM
159
Decatur Capital Management
Georgia
$4.36M +$491K +7,975 +12%
BNP Paribas Financial Markets
160
BNP Paribas Financial Markets
France
$4.32M +$1.65M +26,800 +60%
PI
161
PineBridge Investments
New York
$4.23M -$6.9M -111,931 -62%
PIA
162
Piedmont Investment Advisors
North Carolina
$4.06M
Aviva
163
Aviva
United Kingdom
$3.62M -$33.3K -540 -0.9%
GH
164
GAM Holding
Switzerland
$3.58M -$27.9K -453 -0.8%
PNC Financial Services Group
165
PNC Financial Services Group
Pennsylvania
$3.52M +$442K +7,170 +14%
MA
166
MUFG Americas
New York
$3.5M -$866K -14,053 -20%
TPSF
167
Texas Permanent School Fund
Texas
$3.4M -$256K -4,147 -7%
JHIU
168
Janus Henderson Investors US
Colorado
$3.37M -$5.13M -83,200 -60%
KBC Group
169
KBC Group
Belgium
$3.31M -$590K -9,568 -15%
Public Sector Pension Investment Board (PSP Investments)
170
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.23M -$73.9K -1,200 -2%
TSU
171
TD Securities (USA)
New York
$3.06M +$370 +6 +0%
BGIM
172
Brandywine Global Investment Management
Pennsylvania
$2.86M +$2.68M +43,470 +1,204%
CA
173
Commerzbank Aktiengesellschaft
Germany
$2.76M +$622K +10,094 +29%
FA
174
Financial Advantage
Maryland
$2.71M +$40.7K +660 +1%
JFL
175
Jarislowsky, Fraser Ltd
Quebec, Canada
$2.69M -$91.8K -1,490 -3%

DGX Hedge Fund Activity: Q3 2014 in Review

485 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2014, worth a combined $8.81B — up 0.97% from $8.72B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of DGX and 36 opened new positions — a net loss of 9 holders — while 199 trimmed existing stakes and 158 added.

The largest buyer was Fidelity International, opening a new position worth an estimated $119M. The largest seller was Norges Bank, cutting an estimated $74.9M.

  • 485 institutional investors held Quest Diagnostics (DGX) as of Q3 2014, down from 496 in Q2 2014.
  • Funds reported $8.81B of Quest Diagnostics stock for Q3 2014, up 0.97% quarter-over-quarter.
  • 36 funds opened new Quest Diagnostics positions in Q3 2014 and 45 closed out, a net change of -9 holders.
  • The largest Quest Diagnostics buyer in Q3 2014 was Fidelity International, an estimated $119M added.
  • The largest Quest Diagnostics seller in Q3 2014 was Norges Bank, an estimated $74.9M sold.

Based on aggregated 13F filings for Q3 2014.